We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

41 hedge funds and large institutions have $23.1M invested in Actinium Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 12 increasing their positions, 10 reducing their positions, and 29 closing their positions.

New
Increased
Maintained
Reduced
Closed

171% more call options, than puts

Call options by funds: $1.35M | Put options by funds: $498K

20% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 10

16.82% more ownership

Funds ownership: 0.73% → 17.56% (+17%)

24% less capital invested

Capital invested by funds: $30.5M → $23.1M (-$7.41M)

31% less funds holding

Funds holding: 59 → 41 (-18)

62% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 29

Holders
41
Holders Change
-18
Holders Change %
-30.51%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
12
Reduced
10
Closed
29
Calls
$1.35M
Puts
$498K
Net Calls
+$854K
Net Calls Change
+$849K

Top Buyers

Rank Fund Capital Flow
1
JGC
J. Goldman & Co
New York
+$1.07M
2
BCM
Bridgeway Capital Management
Texas
+$637K
3
RCMNY
Rubric Capital Management (New York)
New York
+$634K
4
Deutsche Bank
Deutsche Bank
Germany
+$525K
5
Bank of New York Mellon
Bank of New York Mellon
New York
+$469K

Top Sellers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
-$4.85M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.27M
3
BlackRock
BlackRock
New York
-$1.13M
4
CH
CVI Holdings
Delaware
-$1M
5
SCM
Sio Capital Management
New York
-$910K
Name Holding Trade Value Shares
Change 		Change in
Stake
Citigroup
26
Citigroup
New York
$10K +$11.1K +1,005 New
Osaic Holdings
27
Osaic Holdings
Arizona
$9K -$16K -1,453 -62%
HFM
28
Hartford Financial Management
Connecticut
$6K -$22 -2 -0.3%
Wells Fargo
29
Wells Fargo
California
$6K +$529 +48 +9%
GFPC
30
Global Financial Private Client
Florida
$2.48K +$2.93K +266 New
Northwestern Mutual Wealth Management
31
Northwestern Mutual Wealth Management
Wisconsin
$1K -$11 -1 -0.9%
AF
32
Allworth Financial
California
$1K – – –
IA
33
IFP Advisors
Florida
$1K – – –
RG
34
Retirement Group
California
$1K – – –
TWA
35
TCI Wealth Advisors
Arizona
$1K – – –
GI
36
Gradient Investments
Minnesota
$1K +$728 +66 New
GEA
37
Glen Eagle Advisors
New Jersey
$58 +$66 +6 New
Renaissance Technologies
38
Renaissance Technologies
New York
– -$1.27M -120,212 Closed
CH
39
CVI Holdings
Delaware
– -$1M -95,016 Closed
SM
40
Sabby Management
Florida
– -$357K -32,410 Closed
VF
41
Virtu Financial
New York
– -$235K -22,287 Closed
Squarepoint
42
Squarepoint
New York
– -$171K -16,188 Closed
AAP
43
Ardsley Advisory Partners
Connecticut
– -$46K -4,333 Closed
OFG
44
Oxford Financial Group
Indiana
– -$38K -3,573 Closed
Charles Schwab
45
Charles Schwab
California
– -$29K -2,674 Closed
ECM
46
ETrade Capital Management
Virginia
– -$28K -2,673 Closed
UBS Group
47
UBS Group
Switzerland
– -$26K -2,437 Closed
SXL
48
Summit X LLC
Missouri
– -$24K -2,273 Closed
DADC
49
D.A. Davidson & Co
Montana
– -$17K -1,650 Closed
Barclays
50
Barclays
United Kingdom
– -$18K -1,583 Closed
1
2
3

ATNM Hedge Fund Activity: Q3 2020 in Review

41 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2020, worth a combined $23.1M — down 24% from $30.5M a quarter earlier.

Sellers outnumbered buyers: 29 funds closed out of ATNM and 11 opened new positions — a net loss of 18 holders — while 10 trimmed existing stakes and 12 added.

The largest buyer was J. Goldman & Co, adding an estimated $1.07M. The largest seller was Consonance Capital Management, cutting an estimated $4.85M.

  • 41 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2020, down from 59 in Q2 2020.
  • Funds reported $23.1M of Actinium Pharmaceuticals stock for Q3 2020, down 24% quarter-over-quarter.
  • 11 funds opened new Actinium Pharmaceuticals positions in Q3 2020 and 29 closed out, a net change of -18 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2020 was J. Goldman & Co, an estimated $1.07M added.
  • The largest Actinium Pharmaceuticals seller in Q3 2020 was Consonance Capital Management, an estimated $4.85M sold.

Based on aggregated 13F filings for Q3 2020.